Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Equine encephalitis' entry elucidated

Nov. 23, 2020

New trial evaluates F4 Pharma's FX-06 in patients with severe COVID-19

Nov. 20, 2020

FDA issues EUA for baricitinib with remdesivir for hospitalized COVID-19 patients

Nov. 20, 2020

Promising preclinical data for AK-119 as potential immunotherapy for COVID-19

Nov. 20, 2020

New HBsAg and HBeAg secretion inhibitors discovered at Nanjing Hepo Pharmaceuticals

Nov. 20, 2020

FLUVID influenza-COVID-19 therapeutic cocktail demonstrates effective antiviral activity

Nov. 20, 2020

Interim data from phase Ib/IIa study of VBI-2601 for chronic hepatitis B

Nov. 19, 2020

BioVersys initiates phase I testing of BV-100 for carbapenem-resistant A. baumannii infections

Nov. 19, 2020

Beta Pharma identifies new HCV NS5A inhibitors

Nov. 19, 2020

Neuro-drug repurposed to treat MDR Gram-negative sepsis

Nov. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...